Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02470728 · ClinicalTrials.gov registry record · NA
Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT02470728 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 60 participants.
The verdict
NCT02470728, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
Pain is a symptom that drives hospital admissions, and pain management is required by most patients during their hospital stay. Further, the use of medications such as opioids can lead to upward-spiraling doses, especially among chronic pain patients whose resource utilization rates are high. Many initiatives aim to reduce the costs of these "high-resource utilizing" patients. One exciting aspect of improving the management of pain is that this may help prevent patients from ever becoming high-cost in the first place. The purpose of this study is to examine the impacts of an early and sustained intervention pathway, in comparison to the current standard of care, for the treatment of pain in opioid tolerant patients. It is hypothesized that patients randomized to the intervention pathway, in comparison to the control, will lead to decreased costs of care, a reduction in opioid usage within 3 and 6 months, and decrease in hospital readmission rates.
Interventions
- OTHER New Clinical Pathway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2016-01 |
| Est. Completion | 2019-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02470728
The ClinicalTrials.gov registry entry for NCT02470728 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which New Clinical Pathway is the first listed.
NCT02470728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02470728 about?
NCT02470728 is a clinical study titled "Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.". Pain is a symptom that drives hospital admissions, and pain management is required by most patients during their hospital stay. Further, the use of medications such as opioids can lead to upward-spiraling doses, especially among chronic pain patients whose resource utilization rates are high. Many i...
What is the current status of trial NCT02470728?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2016-01. Estimated completion is 2019-07-31.
What interventions are being tested in trial NCT02470728?
The interventions under investigation include: New Clinical Pathway (OTHER).
Who is sponsoring clinical trial NCT02470728?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.